Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel M Palefsky

Showing results (1-10 of 245) with videos related to

Pageof 25
Sort By:
Disease Markers|July 14, 2007
HPV infection in menJoel M Palefsky
Cancer Cytopathology|August 4, 2015
Screening to prevent anal cancer: Current thinking and future directionsJoel M Palefsky
Current Opinion in Oncology|July 10, 2009
Anal cancer prevention in HIV-positive men and womenJoel M Palefsky
JAMA|October 23, 2024
Prevention of Anal Cancer in High-Risk IndividualsJoel M Palefsky
Current Opinion in Oncology|September 10, 2003
Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapyJoel M Palefsky
Sexual Health|February 6, 2013
Practising high-resolution anoscopyJoel M Palefsky
Current Opinion in HIV and AIDS|November 10, 2016
Human papillomavirus-associated anal and cervical cancers in HIV-infected individuals: incidence and prevention in the antiretroviral therapy eraJoel M Palefsky
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|March 24, 2010
Human papillomavirus-related disease in men: not just a women's issueJoel M Palefsky
Sexually Transmitted Diseases|June 15, 2012
Antiretroviral therapy and anal cancer: the good, the bad, and the unknownJoel M Palefsky
Human Gene Therapy|February 6, 2010
Addition of a single E2 binding site to the human papillomavirus (HPV) type 16 long control region enhances killing of HPV positive cells via HPV E2 protein-regulated herpes simplex virus type 1 thymidine kinase-mediated suicide gene therapyRachna Sharma, Joel M Palefsky
Pageof 25

Showing results (1-10 of 245) with videos related to

Sort By:
Pageof 25
Disease Markers|July 14, 2007
HPV infection in menJoel M Palefsky
Cancer Cytopathology|August 4, 2015
Screening to prevent anal cancer: Current thinking and future directionsJoel M Palefsky
Current Opinion in Oncology|July 10, 2009
Anal cancer prevention in HIV-positive men and womenJoel M Palefsky
JAMA|October 23, 2024
Prevention of Anal Cancer in High-Risk IndividualsJoel M Palefsky
Current Opinion in Oncology|September 10, 2003
Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapyJoel M Palefsky
Sexual Health|February 6, 2013
Practising high-resolution anoscopyJoel M Palefsky
Current Opinion in HIV and AIDS|November 10, 2016
Human papillomavirus-associated anal and cervical cancers in HIV-infected individuals: incidence and prevention in the antiretroviral therapy eraJoel M Palefsky
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|March 24, 2010
Human papillomavirus-related disease in men: not just a women's issueJoel M Palefsky
Sexually Transmitted Diseases|June 15, 2012
Antiretroviral therapy and anal cancer: the good, the bad, and the unknownJoel M Palefsky
Human Gene Therapy|February 6, 2010
Addition of a single E2 binding site to the human papillomavirus (HPV) type 16 long control region enhances killing of HPV positive cells via HPV E2 protein-regulated herpes simplex virus type 1 thymidine kinase-mediated suicide gene therapyRachna Sharma, Joel M Palefsky
Pageof 25